South & Central America Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The organoids services market in South and Central America is projected to grow significantly, reaching an estimated US$ 806.23 million by 2031, up from US$ 194.86 million in 2024. This growth represents a compound annual growth rate (CAGR) of 22.5% from 2024 to 2031.

Executive Summary and Market Analysis

The market is divided into three main regions: Brazil, Argentina, and the Rest of South and Central America. The anticipated growth in this market is driven by several factors, including a rising incidence of cancer, increased government initiatives, and heightened research and development activities focused on organoids.

Market Segmentation Analysis

The South and Central America organoids services market can be segmented by type, application, and source:

1. By Type: The market includes various organoid types such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is expected to dominate the market share.

2. By Application: The applications of organoids are categorized into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is projected to hold the largest market share in 2024.

3. By Source: The market is divided into two sources: pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment is anticipated to have a larger market share in 2024.

Market Outlook

The advancement of the healthcare sector globally has led to an increased demand for organoids, which in turn drives innovation and development in the market. This includes new product launches, partnerships, and acquisitions. Notable recent developments include:

June 2024: Molecular Devices, LLC opened a new facility in Cardiff, UK, designed for the large-scale production of patient-derived organoids (PDOs) using innovative bioprocess technology.
May 2024: InSphero entered a partnership with Genome Biologics to commercialize a 3D Cardiac Organoid Platform, enhancing heart disease research capabilities.
January 2024: HUB Organoids launched IntegriGut Screen services, utilizing IBD patient-derived organoid monolayers to support the development of new therapies for inflammatory bowel disease (IBD).
July 2023: Molecular Devices expanded its custom organoid line service to cater to high-throughput applications.
February 2023: A strategic collaboration was announced between Molecular Devices and HUB Organoids to advance 3D biology technologies.
December 2022: Molecular Devices acquired Cellesce Ltd. to enhance the production of PDOs for drug screening.
August 2021: STEMCELL Technologies partnered with HUB to provide tissue-derived organoids for preclinical testing.
May 2020: CELLINK collaborated with AstraZeneca to develop 3D bioprinted liver organoids for drug discovery.
February 2020: InnoSer and Organotherapeutics announced a collaboration to commercialize midbrain organoids for Parkinson's disease research.

These developments indicate a robust growth trajectory for the organoid services market, driven by strategic collaborations and technological advancements.

Country Insights

The market is primarily composed of Brazil, Argentina, and the Rest of South and Central America, with Brazil holding the largest market share in 2024. The growth in Brazil can be attributed to increased investments in biotechnology and life sciences, supported by government initiatives and private funding aimed at enhancing research capabilities. The rising prevalence of chronic diseases necessitates more effective drug development and personalized medicine solutions, which organoids can provide by mimicking human organ functions for disease modeling and drug testing. Additionally, collaborations between academic institutions and industry players are fostering the adoption of organoid technologies, translating research into practical applications. The focus on improving healthcare outcomes and the demand for reliable preclinical models are further driving pharmaceutical companies to integrate organoids into their drug discovery processes, benefiting the organoid services market in Brazil.

Company Profiles

Key players in the South and Central America organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Product Code: BMIRE00032027

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Organoids Services Market Landscape

4.1 PEST Analysis

5. South & Central America Organoids Services Market - Key Market Dynamics

5.1 South & Central America Organoids Services Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Demand for Innovative Drug Screening Services
- 5.2.2 Surge in Popularity of Personalized Drugs
5.3 Market Restraints
- 5.3.1 Dearth of Skilled Professionals
5.4 Market Opportunities
- 5.4.1 Increasing Key Developments
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence
5.6 Impact of Drivers and Restraints:

6. South & Central America Organoids Services Market - Analysis

6.1 South & Central America Organoids Services Market Revenue (US$ Million), 2021-2031
6.2 South & Central America Organoids Services Market Forecast Analysis

7. South & Central America Organoids Services Market Analysis - by Type

7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Organoids Services Market Analysis - by Application

8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Organoids Services Market Analysis - by Source

9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Organoids Services Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South & Central America Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South & Central America Organoids Services Market Share - by Type
    - 10.1.1.2.2 Brazil: South & Central America Organoids Services Market Share - by Application
    - 10.1.1.2.3 Brazil: South & Central America Organoids Services Market Share - by Source
  - 10.1.1.3 Argentina: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South & Central America Organoids Services Market Share - by Type
    - 10.1.1.3.2 Argentina: South & Central America Organoids Services Market Share - by Application
    - 10.1.1.3.3 Argentina: South & Central America Organoids Services Market Share - by Source
  - 10.1.1.4 Rest of South & Central America: South & Central America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Organoids Services Market Share - by Type
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Organoids Services Market Share - by Application
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Organoids Services Market Share - by Source

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organoids Services Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Sino Biological Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Eurofins Scientific SE
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Molecular Devices, LLC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 InSphero
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Cyprio
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 InnoSer
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 LABTOO
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 CUSABIO TECHNOLOGY LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Oncodesign Services
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms